Macrophages polarized by Toxoplasma effectors modulate hepatic stellate cells activation
International Conference on Parasitology
August 24-26, 2015 Philadelphia, USA

Deyong Chu, Qingli Luo, Yuanyuan Xie and Jilong Shen

Anhui Medical University, China

Scientific Tracks Abstracts: J Bacteriol Parasitol

Abstract:

Our previous study showed that macrophages can be phenotypically polarized by different Toxoplasma gondii virulent isolates within the genotype Chinese 1 (ToxoDB#9). The virulent Wh3 isolate induced macrophages to polarize toward alternatively activated macrophages (aaMs), whereas the less virulent Wh6 elicited the development of classically activated macrophages (caMs). In order to make clear whether T. gondii virulence determinants, such as effectors rhoptry protein 16 (ROP16) and dense granule protein 15 (GRA15) play an important role in inducing macrophages polarization, we infected RAW264.7 cell strain with lentiviral vectors which contained PEGFP-ROP16 or PEGFP-GRA15 plasmid. The rop16 and gra15 were amplified from Wh3 and PRU (type II) strains, respectively. The results revealed that the RAW264.7 cells transfected with rop16 gave rise to a high expression of ROP16 protein which persistently drove the host cells to aaMs with high expression of arginase-1 (Arg-1), while the gra15 transfection generated the GRA15 expression which continually induced RAW264.7 polarization towards caMs with high expression of inducible nitric oxide synthase (iNOS). Additionally, we subjected the polarized macrophages to mouse haptic stellate cells (HSCs) in transwell culture system and found that the aaMs activated HSCs to myofibroblasts with alpha-smooth muscle actin (α-SMA) and transforming growth factor beta1 (TGF-β1) expression increased. In contrast, caMs deactivate HSCs with α-SMA and TGF-β1 expression decreased. We conclude that the virulenceassociated effectors from different genotype T. gondii isolates (Wh3 and PRU) are crucial to induce phenotypical polarization of macrophages, which involve in the HSCs activation. This result perhaps brings a new way to treat hepatic fibrosis in future.

Biography :

Deyong Chu completed his MD and PhD from Anhui Medical University, China in 2007 and studied as a Visiting Scholar at Chiba University, School of Medicine of Japan. He is a Researcher of the Key Laboratory of Zoonoses and the Key Laboratory of Pathogen Biology of Anhui province. Meanwhile, he works as a Teacher in Department of Human Parasitology of Anhui Medical University. He has published more than 10 papers and currently investigates on the haptic fibrosis of schistosomiasis.

Email: chudeyong@126.com